Inari Medical
(NASDAQ) NARI
Inari Medical Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$574.50M
Net Income (TTM)
$78.58M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
NARI News
3 Under-the-Radar COVID Stocks
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inari Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,300
CEO
Andrew J. Hykes, MBA
Website
www.inarimedical.comHeadquarters
Irvine, CA 92618, US
NARI Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
-3%
Net Income Margin
-0%
Return on Equity
-0%
Return on Capital
-2%
Return on Assets
-0%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$434.56M
Operating Income
$14.03M
EBITDA
$15.19M
Operating Cash Flow
$35.93M
Capital Expenditure
$6.20M
Free Cash Flow
$29.73M
Cash & ST Invst.
$115.45M
Total Debt
$32.05M
Inari Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$153.39M
+21.4%
Gross Profit
$133.54M
+19.4%
Gross Margin
87.06%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
1,300
N/A
Net Income
$18.37M
-680.9%
EBITDA
$7.21M
-268.3%
Quarterly Fundamentals
Net Cash
$78.81M
-75.3%
Accounts Receivable
$84.40M
+21.3%
Inventory
$55.21M
+37.2%
Long Term Debt
$31.14M
+1.7%
Short Term Debt
$3.16M
-3.1%
Return on Assets
-0.24%
N/A
Return on Invested Capital
-2.35%
N/A
Free Cash Flow
$995.00K
-106.9%
Operating Cash Flow
$2.71M
-83.0%